Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000687-41Phase 2Completed
Phase 2, randomised, double-blind trial in hypothyroidism comparing Combined thyroid hormone replacement with Levothyroxine control (2 arms). Primary endpoint: Peripheral tissue response to changes in free T3 and free T4. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000687-41.